Company profile

CHEMED CORP

NYSE:CHEMedical/Nursing Services

Drug pipeline (1)

AssetStageRevenueTrialsStatus
SEPTISOLapproved—0—

Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.

Clinical trials (0)

No records yet.

FDA applications (2)

ApplicationApprovedTypeApplicantProducts
NDA 017423—NDAVESTAL LABORATORIES DIV CHEMED CORP
NDA 017424—NDAVESTAL LABORATORIES DIV CHEMED CORP